力生制药(002393.SZ)：高级管理人员郭晓燕拟减持不超过1.12万股公司股份

Core Viewpoint - The company, Lisheng Pharmaceutical (002393.SZ), announced that senior management personnel, Guo Xiaoyan, plans to reduce her shareholding in the company by selling up to 11,200 shares within three months after a 15 trading day period from the announcement date [1] Summary by Categories Shareholding Reduction Plan - Guo Xiaoyan holds 114,800 shares in the company and intends to sell no more than 11,200 shares [1] - The planned reduction represents a maximum of 0.0044% of the company's total share capital after excluding shares in the repurchase special account [1]